Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for AVDL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
September 30, 2025 97.24M
June 30, 2025 96.78M
March 31, 2025 96.63M
December 31, 2024 96.52M
September 30, 2024 96.34M
June 30, 2024 96.20M
March 31, 2024 96.10M
December 31, 2023 95.02M
September 30, 2023 94.59M
June 30, 2023 94.52M
March 31, 2023 64.97M
December 31, 2022 63.37M
September 30, 2022 61.37M
June 30, 2022 59.53M
March 31, 2022 59.52M
December 31, 2021 59.11M
September 30, 2021 59.10M
June 30, 2021 58.98M
March 31, 2021 58.98M
December 31, 2020 58.88M
September 30, 2020 58.73M
June 30, 2020 58.62M
March 31, 2020 46.89M
December 31, 2019 37.52M
September 30, 2019 37.45M
Date Value
June 30, 2019 37.36M
March 31, 2019 37.36M
December 31, 2018 37.31M
September 30, 2018 37.01M
June 30, 2018 36.74M
March 31, 2018 37.64M
December 31, 2017
September 30, 2017
June 30, 2017
March 31, 2017
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015 41.24M
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014
September 30, 2014 38.94M
June 30, 2014
March 31, 2014 38.27M
December 31, 2013
September 30, 2013
June 30, 2013

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Jazz Pharmaceuticals Plc 64.80M
Perrigo Co. Plc 138.70M
GH Research Plc 68.64M
Cosmo NV --
Alkermes Plc 167.54M